Nana Pogosova

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

Martin O’Donnell, Siu Lim Chin, Sumathy Rangarajan et al. · The Lancet · 2016 · 2.1K citations · Full text

Cerebrovascular Disease, Case-control Study, Thrombosis +16

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Kornelia Kotseva, David Wood, Dirk De Bacquer et al. · European Journal of Preventive Cardiology · 2015 · 985 citations · Full text

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kornelia Kotseva, Guy De Backer, Dirk De Bacquer et al. · European Journal of Preventive Cardiology · 2019 · 887 citations · Full text